A-134974: A novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats

Brain Research

Volumn 905, Issue 1-2, 2001, Pages 104-110

  Zhu, Chang Z ^a   Mikusa, Joe ^a   Chu, Katharine L ^a   Cowart, Marlon ^a   Kowaluk, Elizabeth A ^a   Jarvis, Michael F ^a   McGaraughty, Steve ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Adenosine; Adenosine kinase inhibitor; Allodynia; Neuropathic pain

Indexed keywords

A 134974; ADENOSINE; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; THEOPHYLLINE DERIVATIVE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; MALE; MOTOR COORDINATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT;

ADENOSINE KINASE; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYPERALGESIA; MALE; NERVE CRUSH; NOCICEPTORS; NUCLEOSIDES; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHODIESTERASE INHIBITORS; PHYSICAL STIMULATION; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; THEOPHYLLINE;

EID: 0035968056     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02512-4     Document Type: Article

References (35)

1. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
2. Pain assessment and evaluation of patients who have neuropathic pain
3. The caridac effects of adenosine
4. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart
5. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain
6. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats
7. Spinal opioid receptors and adenosine release: Neurochemical and behavioral characterization of opioid subtypes
8. Prevention and treatment of the complications of diabetes mellitus
9. Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo
10. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: Pharmacological activities and potent inhibition of adenosine kinase
11. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: Dissociation from gastrointestinal effects in mice
12. Efficient analysis of experimental observations
13. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia
14. Intrathecal adenosine intereacts with spinal noradrenergic system to produce antinociception in nerver-injured rats
15. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices
16. Psychomotor aspects of adenosine receptor activation
17. ABT-702 [4-amino-5-(3-bromopheny)-7-(6-morpholino-pyridin-3-yl)pyrido{2,3-d} pyrimidine], a noval orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. 1. In vitro characterization and acute antinociceptive effects in the mouse
18. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice
19. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
20. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice
21. ABT-702 [4-amino-5-(3-bromopheny)-7-(6-morpholino-pyridin-3-yl)pyrido{2, 3-d}pyrimidine], a noval orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat
22. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain
23. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model
24. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
25. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain
26. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: Evaluation of the sites of action
27. Acadesine: Prototype adenosine regulating agent for treating myocardial ischemia-reperfusion injury
28. Adenosine and the concept of "retaliatory metabolites"
29. Antinociception by adenosine analogs and an adenosine kinase inhibitor: Dependence on formalin concentration
30. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat
31. Adenosine receptor activation and nociception
32. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test
33. Adenosine release may mediate spinal analgesia by morphine
34. Chronic catherization of the spinal subarachnoid space